As DC101, a murine VEGFR2 inhibitor, cannot target the human tumor cells in PDXs, but can target both murine ECs and CAFs, we explored whether DC101 acts directly on ECs and mNos3 transcription or whether CAFs play a role in this. The gene discussed is KDR; the disease is neoplasm.